CCKBR and medullary thyroid gland carcinoma: The objectives of the GRAN-T-MTC study were to assess the safety of the intravenous administration of the CCK2R/gastrin analogue CP04, as well as the diagnostic potential, biodistribution, and dosimetry of [111In]In-CP04 in cancerous and normal tissue.